These data highlight the fundamental difference between microprolactinomas and the larger macroprolactinomas, the latter involving a high percentage (20.7–31.0%) of patients with persistent hypogonadism despite normalization of prolactin levels [27–29]. Here, PRL is linked to hypogonadism.